Cruise ships are often associated with luxury, adventure, and relaxation, but there’s one ship that carries a dark and deadly history. This particular cruise ship, still operating today, has a tragic ...

Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

Bristol Myers Squibb & Co. (NYSE:BMY) on Friday announced topline results from the Phase 3 INDEPENDENCE trial evaluating ...

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Psychological safety—a shared belief among team members that it’s OK to speak up with candor—has become a popular concept. However, as its popularity has grown, so too have misconceptions ...

Sarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy ...

ZoomRx surveyed 57 neurologists in the U.S. this month, revealing that no single drug brand holds more than 5% of top-of-mind ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...

The existence of “magnetic nanoparticles” in COVID mRNA vaccines has raised significant concerns among scientists and public health advocates alike. A recent study conducted by reputable researchers ...

It might seem counterintuitive to buy safe dividend stocks with “boring” underlying businesses when everyone else is ...